Pharmicell Co., Ltd. (KRX:005690)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,590.00
-100.00 (-1.03%)
Feb 11, 2025, 12:22 PM KST

Pharmicell Revenue

Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.

Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
20.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
678.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 201333.41B22.29B200.63%
Dec 31, 201211.11B829.38M8.07%
Dec 31, 201110.28B3.07B42.47%
Dec 31, 20107.22B28.94M0.40%
Dec 31, 20097.19B-1.14B-13.68%
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience 201.30B
Hanmi Pharm. 1,495.50B
Peptron 2.41B
Hanall Biopharma 134.24B
Revenue Rankings